Methods: A retrospective chart review was conducted on all adolescents seen at a university based outpatient clinic between January 2013 to January 2015. Males and Females aged 11-18 years who were seen for well child or vaccine only visits were included in this study. Charts were examined for comparing the acceptance rates of the HPV vaccine with the Tdap booster and Menactra vaccines.
Results: We identified a total of 203 patients between 11-18 years in the period from January 2013 to January 2015 with 77 (38%) being female and 126 (62%) being male. Out of 77 female patients 24 (31%) refused the HPV vaccine and out of 126 male patient 70 (56%) refused the HPV vaccine. Only 7 (3%) of 203 patients refused both the Tdap and Menactra vaccines. Of these 7 patients 5 (71%) were female and 2 (29%) were male. The 7 patients who refused the Menactra and Tdap vaccines also refused the HPV vaccine.
Conclusion: The acceptance rate of the HPV vaccine in adolescent males and females compared to the meningitis and Tdap booster vaccines continues to be low. Prospective studies should address the implementation of an effective program to increase the acceptance rate of HPV vaccination by educational strategies aimed at involving parents and their children supported by general pediatricians and public health professionals.
A. Arun, None